EMBO and FEBS announce Molly Stevens of Imperial College London, UK, as the recipient of the FEBS | EMBO Women in Science Award 2021.
Category: Press releases
EMBO Press announces the appointment of Bernd Pulverer, Head of Scientific Publishing at EMBO, as Chief Editor of EMBO Reports.
EMBO Press announces the appointment of immunologist Facundo Batista, PhD, as Chief Editor of The EMBO Journal.
EMBO Installation Grants support eight early-career scientists to establish independent laboratories
EMBO is pleased to announce the award of Installation Grants to eight scientists in the early stages of setting up their independent laboratories in Lithuania, Poland, Portugal and Turkey.
Development of an in vitro human-derived tissue model for studying virus infection and disease progression in the alveolar cells of the lungs responsible for oxygen and carbon dioxide exchange with the blood might enable the study of possible therapies for acute respiratory distress syndrome (ARDS) triggered by SARS-CoV-2.
A team of Japanese scientists has revealed a mechanism associated with an increased risk of behavioural defects among offspring of older fathers in a mouse study, with strong indications similar processes are involved in humans.
EMBO publicly launches the Early Evidence Base site, an experimental platform that blends human scientific expertise with artificial intelligence (AI) to highlight scientific findings posted in preprints. Preprints are manuscripts that are publicly shared online by researchers before formal publication in a peer-reviewed journal.
Molecular markers in the blood shown to be predictive of severe COVID-19 outcomes resulting from SARS-CoV-2 coronavirus infection have been identified in a study by a Chinese research team. The study results extend understanding of the pathophysiology and clinical progress of COVID-19 with potential for identifying early during the course of infection which individuals are most at risk of developing severe conditions and requiring hospital care.
EMBO congratulates nine life scientists on their selection as EMBO Global Investigators. They form the second cohort of the Global Investigator Network that was launched in 2019 and will start their four-year tenure in January 2021. The new Global Investigators will receive financial support for several networking, collaboration and training activities.
EMBO is pleased to announce that thirty life scientists have been selected as EMBO Young Investigators. They will join the existing network of 73 current and 384 former members of the programme. The new EMBO Young Investigators will receive financial and practical support for a period of four years, starting in January 2021.